GROUP ONE TRADING, L.P. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is and the CUSIP is 363225902. A total of 3 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,856
+57.0%
9,300
+17.7%
0.00%
Q2 2023$11,376
-33.9%
7,900
-3.7%
0.00%
Q1 2023$17,220
+702.0%
8,200
+331.6%
0.00%
Q4 2022$2,147
-84.7%
1,900
-77.9%
0.00%
Q3 2022$14,000
-6.7%
8,600
-27.1%
0.00%
Q2 2022$15,000
-75.8%
11,800
-69.1%
0.00%
Q1 2022$62,000
-58.9%
38,200
-47.7%
0.00%
Q4 2021$151,000
-85.6%
73,100
-72.9%
0.00%
-100.0%
Q3 2021$1,045,000
-3.5%
269,300
-20.4%
0.00%0.0%
Q2 2021$1,083,000
+1646.8%
338,300
+1078.7%
0.00%
Q1 2021$62,000
+148.0%
28,700
+160.9%
0.00%
Q4 2020$25,000
-76.0%
11,000
-71.7%
0.00%
Q3 2020$104,000
-23.5%
38,900
-12.6%
0.00%
-100.0%
Q2 2020$136,000
+147.3%
44,500
+57.2%
0.00%
Q1 2020$55,000
-48.6%
28,300
-24.5%
0.00%
-100.0%
Q4 2019$107,000
-13.7%
37,500
+10.9%
0.00%0.0%
Q3 2019$124,000
+69.9%
33,800
+91.0%
0.00%0.0%
Q2 2019$73,000
-85.1%
17,700
-81.5%
0.00%
-80.0%
Q1 2019$489,000
+154.7%
95,700
+70.9%
0.01%
+150.0%
Q4 2018$192,000
-59.1%
56,000
-28.4%
0.00%
-50.0%
Q3 2018$470,000
+121.7%
78,200
+134.8%
0.00%
+100.0%
Q2 2018$212,000
-61.0%
33,300
-71.0%
0.00%
-60.0%
Q1 2018$544,000
-46.5%
114,700
-62.3%
0.01%
-28.6%
Q4 2017$1,017,000
+237.9%
304,400
+114.1%
0.01%
+133.3%
Q3 2017$301,000
-33.7%
142,200
-22.9%
0.00%
-40.0%
Q2 2017$454,000
-20.1%
184,400
-25.4%
0.01%
-28.6%
Q1 2017$568,000247,1000.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 10$00.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders